Research ArticleClinical Studies

Low-dose IL-2 Therapy Reduces HCV RNA and HBV DNA: Case Report

R. TOMOVA, K. ANTONOV, A. IVANOVA, J.J.L. JACOBS, J.W. KOTEN, W. DEN OTTER and Z. KRASTEV
Anticancer Research December 2009, 29 (12) 5241-5244;

Article Information

vol. 29 no. 12 5241-5244
PubMed 
20044643
Published By 
International Institute of Anticancer Research
Print ISSN 
0250-7005
Online ISSN 
1791-7530
History 
  • Received July 10, 2009
  • Revision received November 22, 2009
  • Accepted November 25, 2009
  • Published online December 31, 2009.
Copyright & Usage 
Copyright© 2009 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved

Author Information

  1. R. TOMOVA1,
  2. K. ANTONOV1,
  3. A. IVANOVA1,
  4. J.J.L. JACOBS2,
  5. J.W. KOTEN2,
  6. W. DEN OTTER2 and
  7. Z. KRASTEV1
  1. 1Clinic of Gastroenterology, St. Ivan Rilski University Hospital, Sofia, Bulgaria
  2. 2Department of Urology, VU University Medical Centre, 1007 MB, Amsterdam, The Netherlands
  1. Correspondence to: Radosveta Tomova, Clinic of Gastroenterology, St Ivan Rilski University Hospital, Ivan Geshov Bvd 15, Sofia, Postal Code 1431, Bulgaria. Tel: +359 28510816, Fax: +359 28510816, e-mail: raditomova{at}yahoo.com
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Low-dose IL-2 Therapy Reduces HCV RNA and HBV DNA: Case Report
R. TOMOVA, K. ANTONOV, A. IVANOVA, J.J.L. JACOBS, J.W. KOTEN, W. DEN OTTER, Z. KRASTEV
Anticancer Research Dec 2009, 29 (12) 5241-5244;
Twitter logo Facebook logo Mendeley logo

Jump to section